Bausch Health Companies Inc. BVF.F Stock
Bausch Health Companies Inc. Price Chart
Bausch Health Companies Inc. BVF.F Financial and Trading Overview
| Bausch Health Companies Inc. stock price | 8.17 EUR |
| Previous Close | 6.64 EUR |
| Open | 6.62 EUR |
| Bid | 6.57 EUR x 31000 |
| Ask | 6.91 EUR x 31000 |
| Day's Range | 6.62 - 6.62 EUR |
| 52 Week Range | 4.31 - 8.99 EUR |
| Volume | 250 EUR |
| Avg. Volume | 414 EUR |
| Market Cap | 2.41B EUR |
| Beta (5Y Monthly) | 0.954225 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.51 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | November 10, 2010 |
| 1y Target Est | 35.82 EUR |
BVF.F Valuation Measures
| Enterprise Value | 23.02B EUR |
| Trailing P/E | N/A |
| Forward P/E | 1.4057324 |
| PEG Ratio (5 yr expected) | 1.77 |
| Price/Sales (ttm) | 0.2954867 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.824 |
| Enterprise Value/EBITDA | 8.4 |
Trading Information
Bausch Health Companies Inc. Stock Price History
| Beta (5Y Monthly) | 0.954225 |
| 52-Week Change | -2.047% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.99 EUR |
| 52 Week Low | 4.31 EUR |
| 50-Day Moving Average | 6.64 EUR |
| 200-Day Moving Average | 6.88 EUR |
BVF.F Share Statistics
| Avg. Volume (3 month) | 414 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 363.72M |
| Float | 308.46M |
| Short Ratio | N/A |
| % Held by Insiders | 7.78% |
| % Held by Institutions | 81.16% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -4.37% |
| Operating Margin (ttm) | 16.91% |
| Gross Margin | 70.61% |
| EBITDA Margin | 33.61% |
Management Effectiveness
| Return on Assets (ttm) | 3.16% |
| Return on Equity (ttm) | -17750.00000000000000000000000000000000% |
Income Statement
| Revenue (ttm) | 8.15B EUR |
| Revenue Per Share (ttm) | 22.48 EUR |
| Quarterly Revenue Growth (yoy) | 1.40% |
| Gross Profit (ttm) | 5.76B EUR |
| EBITDA | 2.74B EUR |
| Net Income Avi to Common (ttm) | -357000000 EUR |
| Diluted EPS (ttm) | -0.92 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 518M EUR |
| Total Cash Per Share (mrq) | 1.42 EUR |
| Total Debt (mrq) | 20.65B EUR |
| Total Debt/Equity (mrq) | 14243.45 EUR |
| Current Ratio (mrq) | 1.08 |
| Book Value Per Share (mrq) | -2.2 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -511000000 EUR |
| Levered Free Cash Flow (ttm) | 882.25M EUR |
Profile of Bausch Health Companies Inc.
| Country | Germany |
| State | QC |
| City | Laval |
| Address | 2150 St. ElzEar Boulevard West |
| ZIP | H7L 4A8 |
| Phone | 514-744-6792 |
| Website | https://www.bauschhealth.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 19900 |
Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. was incorporated in 2013 and is headquartered in Laval, Canada.
Q&A For Bausch Health Companies Inc. Stock
What is a current BVF.F stock price?
Bausch Health Companies Inc. BVF.F stock price today per share is 8.17 EUR.
How to purchase Bausch Health Companies Inc. stock?
You can buy BVF.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bausch Health Companies Inc.?
The stock symbol or ticker of Bausch Health Companies Inc. is BVF.F.
Which industry does the Bausch Health Companies Inc. company belong to?
The Bausch Health Companies Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Bausch Health Companies Inc. have in circulation?
The max supply of Bausch Health Companies Inc. shares is 369.18M.
What is Bausch Health Companies Inc. Price to Earnings Ratio (PE Ratio)?
Bausch Health Companies Inc. PE Ratio is now.
What was Bausch Health Companies Inc. earnings per share over the trailing 12 months (TTM)?
Bausch Health Companies Inc. EPS is -1.51 EUR over the trailing 12 months.
Which sector does the Bausch Health Companies Inc. company belong to?
The Bausch Health Companies Inc. sector is Healthcare.